NSE BSE
nath bio-genes (i) ltd stock

NATH BIO-GENES (I) LTD Share Price

- - (%)
Sector: -

11065

537291

NATHBIOGEN

img img img img
No Data Available

NATH BIO-GENES (I) LTD Share Price Update


As of the latest trading session, NATH BIO-GENES (I) LTD share price is currently at 196, which is up by 1.39 from its previous closing. Today, the stock has fluctuated between 193.05 and 200.00. Over the past year, NATH BIO-GENES (I) LTD has achieved a return of 18.11 %. In the last month alone, the return has been 2.39 %.

NATH BIO-GENES (I) LTD Performance

Day Range

Low193.05 High200.00
195.90

52 Week Range

Low 159.00 High 244.60
195.90

Open Price

193.05

Prev. Close

194.60

Volume (Shares)

11838.00

Total traded value

23.19

Upper Circuit

204.30

Lower Circuit

184.90

Note: The current prices & values are delayed, Login to your account for live updates.

NATH BIO-GENES (I) LTD Fundamentals


(Standalone)

Market Cap (Cr) 372.47
PE Ratio (TTM) 9.19
Book Value / Share 321.32
Beta 1.01
ROE 6.31%
EPS (TTM) 19.33
Dividend Yield 1.03%
Net Profit Qtr (Cr) 3.21

NATH BIO-GENES (I) LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 43.04
Operating Expense 40.60
Net Profit 3.21
Net Profit Margin (%) 7.45
Earnings Per Share (EPS) 2.18
EBITDA 4.91
Effective Tax Rate (%) 21.60
Particulars DEC 2023 (Values in Cr)
Revenue 31.74
Operating Expense 29.55
Net Profit 3.96
Net Profit Margin (%) 12.47
Earnings Per Share (EPS) 2.09
EBITDA 5.82
Effective Tax Rate (%) 34.68
Particulars SEP 2023 (Values in Cr)
Revenue 22.57
Operating Expense 20.68
Net Profit 1.60
Net Profit Margin (%) 7.08
Earnings Per Share (EPS) 0.85
EBITDA 5.14
Effective Tax Rate (%) 17.94
Particulars JUN 2023 (Values in Cr)
Revenue 235.28
Operating Expense 201.76
Net Profit 33.40
Net Profit Margin (%) 14.19
Earnings Per Share (EPS) 17.58
EBITDA 37.13
Effective Tax Rate (%) 0.65
Particulars MAR 2023 (Values in Cr)
Revenue 44.92
Operating Expense 43.35
Net Profit 1.59
Net Profit Margin (%) 3.53
Earnings Per Share (EPS) 0.84
EBITDA 4.34
Effective Tax Rate (%) 12.63
Particulars MAR 2024 (Values in Cr)
Revenue 332.62
Operating Expense 294.60
Net Profit 40.18
Net Profit Margin (%) 12.07
Earnings Per Share (EPS) 21.63
EBITDA 51.03
Effective Tax Rate (%) 5.04
Particulars MAR 2023 (Values in Cr)
Revenue 301.29
Operating Expense 265.53
Net Profit 35.17
Net Profit Margin (%) 11.67
Earnings Per Share (EPS) 18.50
EBITDA 49.44
Effective Tax Rate (%) 3.16
Particulars MAR 2022 (Values in Cr)
Revenue 278.36
Operating Expense 254.64
Net Profit -67.17
Net Profit Margin (%) -24.13
Earnings Per Share (EPS) -35.43
EBITDA -49.53
Effective Tax Rate (%) -6.24
Particulars MAR 2021 (Values in Cr)
Revenue 307.56
Operating Expense 252.48
Net Profit 55.66
Net Profit Margin (%) 18.09
Earnings Per Share (EPS) 29.29
EBITDA 68.38
Effective Tax Rate (%) 1.92
Particulars MAR 2020 (Values in Cr)
Revenue 279.89
Operating Expense 233.21
Net Profit 50.48
Net Profit Margin (%) 18.03
Earnings Per Share (EPS) 26.33
EBITDA 56.51
Effective Tax Rate (%) -4.08
Particulars MAR 2023 (Values in Cr)
Book Value / Share 301.61
ROE % 6.28
ROCE % 7.03
Total Debt to Total Equity 0.18
EBITDA Margin 16.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 285.16
ROE % 4.38
ROCE % 5.64
Total Debt to Total Equity 0.17
EBITDA Margin 14.04
Particulars MAR 2013 (Values in Cr)
Book Value / Share 35.91
ROE % 22.77
ROCE % 23.41
Total Debt to Total Equity 0.29
EBITDA Margin 14.87
Particulars MAR 2012 (Values in Cr)
Book Value / Share 28.57
ROE % 20.12
ROCE % 18.67
Total Debt to Total Equity 0.24
EBITDA Margin 12.57
Particulars MAR 2023 (Values in Cr)
Book Value / Share 301.70
ROE % 6.31
ROCE % 7.06
Total Debt to Total Equity 0.18
EBITDA Margin 16.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 285.19
ROE % 4.12
ROCE % 5.32
Total Debt to Total Equity 0.17
EBITDA Margin 14.05
Particulars MAR 2021 (Values in Cr)
Book Value / Share 322.71
ROE % 9.51
ROCE % 9.74
Total Debt to Total Equity 0.15
EBITDA Margin 22.25
Particulars MAR 2020 (Values in Cr)
Book Value / Share 293.42
ROE % 9.48
ROCE % 9.21
Total Debt to Total Equity 0.12
EBITDA Margin 20.23
Particulars MAR 2019 (Values in Cr)
Book Value / Share 267.09
ROE % 7.87
ROCE % 8.25
Total Debt to Total Equity 0.09
EBITDA Margin 19.76
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 37.99
Total Assets 792.79
Total Liabilities 792.79
Total Equity 573.15
Share Outstanding 19004000
Price to Book Ratio 0.47
Return on Assets (%) 4.41
Return on Capital (%) 5.16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.18
Total Assets 739.48
Total Liabilities 739.48
Total Equity 541.92
Share Outstanding 19004000
Price to Book Ratio 0.75
Return on Assets (%) -9.11
Return on Capital (%) -10.61
Particulars MAR 2013 (Values in Cr)
Cash & Short Term Investments 2.48
Total Assets 158.28
Total Liabilities 158.28
Total Equity 57.47
Share Outstanding 16004000
Price to Book Ratio 0.00
Return on Assets (%) 7.42
Return on Capital (%) 15.49
Particulars MAR 2012 (Values in Cr)
Cash & Short Term Investments 3.29
Total Assets 119.95
Total Liabilities 119.95
Total Equity 45.72
Share Outstanding 16004000
Price to Book Ratio 0.00
Return on Assets (%) 7.67
Return on Capital (%) 16.83
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 37.98
Total Assets 792.97
Total Liabilities 792.97
Total Equity 573.35
Share Outstanding 19004000
Price to Book Ratio 0.47
Return on Assets (%) 4.43
Return on Capital (%) 5.18
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.16
Total Assets 739.53
Total Liabilities 739.53
Total Equity 541.96
Share Outstanding 19004000
Price to Book Ratio 0.75
Return on Assets (%) -9.10
Return on Capital (%) -10.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 29.21
Total Assets 789.51
Total Liabilities 789.51
Total Equity 613.27
Share Outstanding 19004000
Price to Book Ratio 0.93
Return on Assets (%) 7.05
Return on Capital (%) 7.8
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 21.98
Total Assets 729.94
Total Liabilities 729.94
Total Equity 557.61
Share Outstanding 19004000
Price to Book Ratio 0.46
Return on Assets (%) 6.91
Return on Capital (%) 8.05
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 21.37
Total Assets 646.06
Total Liabilities 646.06
Total Equity 507.58
Share Outstanding 19004000
Price to Book Ratio 1.73
Return on Assets (%) 5.94
Return on Capital (%) 6.8
Particulars MAR 2023 (Values in Cr)
Net Income 36.16
Cash from Operations 39.28
Cash from Investing -2.88
Cash from Financing -1.66
Net change in Cash 33.81
Free Cash Flow 41.76
Particulars MAR 2022 (Values in Cr)
Net Income -63.43
Cash from Operations 19.92
Cash from Investing -19.85
Cash from Financing -22.23
Net change in Cash -25.03
Free Cash Flow 21.02
Particulars MAR 2023 (Values in Cr)
Net Income 36.31
Cash from Operations 39.28
Cash from Investing -2.88
Cash from Financing -1.66
Net change in Cash 33.81
Free Cash Flow 41.76
Particulars MAR 2022 (Values in Cr)
Net Income -63.38
Cash from Operations 19.92
Cash from Investing -19.86
Cash from Financing -22.23
Net change in Cash -25.04
Free Cash Flow 21.03
Particulars MAR 2021 (Values in Cr)
Net Income 56.75
Cash from Operations 1.41
Cash from Investing -10.28
Cash from Financing 16.40
Net change in Cash 7.23
Free Cash Flow 12.96
Particulars MAR 2020 (Values in Cr)
Net Income 48.50
Cash from Operations 10.99
Cash from Investing -14.43
Cash from Financing 5.56
Net change in Cash 0.60
Free Cash Flow 15.23
Particulars MAR 2019 (Values in Cr)
Net Income 38.86
Cash from Operations -20.21
Cash from Investing -20.48
Cash from Financing 20.13
Net change in Cash -23.27
Free Cash Flow 2.08
Company Name Price P/E P/B Market Cap 52 Week Low/High
NATH BIO-GENES (I) LTD 194.30 10.21 0.60 369.25 159.40 / 243.70
Nath Bio-Genes (India) Ltd 29.00 0.00 -0.52 18.86 0.00 / 0.00
JAYKAY ENTERPRISES LTD. 130.75 88.95 4.26 764.33 41.80 / 169.00
MODI RUBBER LTD 97.00 15.57 0.37 242.89 59.01 / 119.00
THOMAS COOK (INDIA) LTD 213.35 38.79 6.60 10040.02 59.47 / 228.15
Company Name Price P/E P/B Market Cap 52 Week Low/High
NATH BIO-GENES (I) LTD 194.30 10.05 0.60 369.25 159.40 / 243.70
Nath Bio-Genes (India) Ltd 29.00 0.00 -0.53 18.86 0.00 / 0.00
FGP LTD. 9.31 42.32 3.27 11.08 4.30 / 9.32
JAYKAY ENTERPRISES LTD. 130.75 59.16 4.74 764.33 41.80 / 169.00
MPIL CORPORATION LTD. 589.95 50.95 2.17 33.63 217.55 / 1264.05

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 190.60
  • 26 Days 194.90
  • 10 Days 193.00
  • 50 Days 195.10
  • 12 Days 194.40
  • 100 Days 198.60
  • 20 Days 194.50
  • 200 Days 208.70
194.72
PIVOT
First Resistance 199.78
Second Resistance 204.97
Third Resistance 210.03
First Support 189.53
Second Support 184.47
Third Support 179.28
RSI 35.87
MACD -0.57
Commodity Channel Index (CCI) -38.64
ADX 17.04
Williams % R -65.35

Over 1 Month

down

2.39

Over 3 Months

down

-11.01

Over 6 Months

down

-2.79

Over 1 Year

down

18.11

Over 3 Years

down

-23.31

Over 5 Years

down

-13.67

NATH BIO-GENES (I) LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

NATH BIO-GENES (I) LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
49.76
Promoter Holdings
45.59
FII
0.26
DII
4.37
Promoter Shares(Pledge Percentage)
16.38
Name Category Shares Shares%
Ashu Farms Llp Shareholding of Promoter and Promoter Group 2598949.0 13.68
Akash Farms Llp Shareholding of Promoter and Promoter Group 2326283.0 12.24
Mayo Farms Llp Public Shareholding 1087339.0 5.72
Tapovan Farms Llp Public Shareholding 984191.0 5.18
Aditya Birla Sun Life Trustee Private Limited A/c Aditya Birla Sun Life Pure Value Fund Public Shareholding 828595.0 4.36
Emerald Seeds Private Limited Shareholding of Promoter and Promoter Group 690000.0 3.63
Tingli Finvest Pvt Ltd Shareholding of Promoter and Promoter Group 562360.0 2.96
Nath Industries Limited Shareholding of Promoter and Promoter Group 532000.0 2.8
Barkha Farms Llp Shareholding of Promoter and Promoter Group 522830.0 2.75
Nath Royal Ltd Shareholding of Promoter and Promoter Group 494692.0 2.6
Satpal Khattar Public Shareholding 400000.0 2.1
Ferry Fax Farms Private Limited Shareholding of Promoter and Promoter Group 307644.0 1.62
Pithambar Farms Private Limited Shareholding of Promoter and Promoter Group 250000.0 1.32
Meghal Bakulesh Shah Public Shareholding 248099.0 1.31
Arati Farms Private Limited Shareholding of Promoter and Promoter Group 202641.0 1.07
Nath Biotechnologies Ltd Shareholding of Promoter and Promoter Group 101200.0 0.53
Prabha Farms Private Limited Shareholding of Promoter and Promoter Group 75271.0 0.4
Jeevan Investment & Finance Pvt Ltd Shareholding of Promoter and Promoter Group 219.0 0.0
Paresh Farms Private Limited Shareholding of Promoter and Promoter Group 374.0 0.0
Jeevanlata Nandkishor Kagliwal Shareholding of Promoter and Promoter Group 293.0 0.0
Nandkishor Laxminarayan Kagliwal Shareholding of Promoter and Promoter Group 146.0 0.0

NATH BIO-GENES (I) LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-07-04 2.0 Final 2023-06-30 Equity shares 2022-06-23 2.0 Final 2022-06-25 Equity shares 2021-08-18 2.0 Final 2021-08-22 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About NATH BIO-GENES (I) LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by NATH BIO-GENES (I) LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Nath Bio-Genes (India) Ltd?

Answer Field

The share price of Nath Bio-Genes (India) Ltd for NSE is ₹ 196 and for BSE is ₹ 196.6.

What is the Market Cap of Nath Bio-Genes (India) Ltd?

Answer Field

The market cap of Nath Bio-Genes (India) Ltd for NSE is ₹ 372.47 Cr. and for BSE is ₹ 373.61 Cr. as of now.

What is the 52 Week High and Low of Nath Bio-Genes (India) Ltd?

Answer Field

The 52 Week High and Low of Nath Bio-Genes (India) Ltd for NSE is ₹ 244.60 and ₹ 159.00 and for BSE is ₹ 243.70 and ₹ 159.40.

How to Buy Nath Bio-Genes (India) Ltd share?

Answer Field

You can trade in Nath Bio-Genes (India) Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Nath Bio-Genes (India) Ltd?

Answer Field

The 1 year returns on the stock has been 18.11%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader